Patents Assigned to IMMIX CORPORATION
  • CANCER THERAPEUTICS
    Publication number: 20150110877
    Abstract: The invention relates to the treatment of cancer. In one embodiment, the present invention provides a composition comprising a micelle construct attached to a glut-1 antibody and a curcumin molecule. In another embodiment, the present invention provides a method of treating colon and/or breast cancer by administering a therapeutically effective amount of composition comprising a targeted construct attached to an inhibitor of NF-kB.
    Type: Application
    Filed: March 15, 2013
    Publication date: April 23, 2015
    Applicant: IMMIX CORPORATION
    Inventors: Sean Senn, Ilya Rachman